Multivariate analyses of immune reconstitution in children after allo-SCT: risk-estimation based on age-matched leukocyte sub-populations
Successful SCT for Nijmegen breakage syndrome
Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allografting
Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML
BU/melphalan and auto-SCT in AML patients in first CR: a ‘Gruppo Italiano Trapianto di Midollo Osseo (GITMO)’ retrospective study
Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation
Patient and family education in HSCT: improving awareness of respiratory virus infection and influenza vaccination. A descriptive study and brief intervention
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD
Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantation
The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation
Sequential Organ Failure Assessment predicts the outcome of SCT recipients admitted to intensive care unit
Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning
Hepatocytes of donor origin in recipient liver after hematopoietic SCT in β-thalassemia major patients
Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange
Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT
Absence of IL–23p19 in donor allogeneic cells reduces mortality from acute GVHD
IL–21 is critical for GVHD in a mouse model
Early thrombin generation and impaired fibrinolysis after SCT associate with acute GVHD
Suboptimal long-term physical performance in children and young adults after pediatric allo-SCT
The quality of life of adult survivors of childhood hematopoietic cell transplant
Functional performance status of hematopoietic SCT recipients in the sub-acute phase of recovery
Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)
Adopting autologous hematopoietic stem cells with non-functional CCR5 and CXCR4 against HIV
Self-limited hemolysis due to anti-D passenger lymphocyte syndrome in allogeneic hematopoietic stem cell transplantation
Glutathione S -transferase T1 is a potential new target for the hepatic component of graft vs host disease after HSCT
Herpes simplex virus encephalitis after allogeneic transplantation: an instructive case
Posterior reversible encephalopathy syndrome as a consequence of high dose steroid administration after autologous PBSCT
Target blood concentrations of CYA and tacrolimus in randomized controlled trials for the prevention of acute GVHD after hematopoietic SCT
Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin
Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors
Diffuse alveolar hemorrhage after unrelated cord blood transplantation
Efficacy of lenalidomide in an sAML patient with del 5q relapsing after reduced-intensity allogeneic stem cell transplantation performed in complete remission
Long-term remission after CD34+-selected PBSCT in a patient with advanced intra-abdominal desmoplastic small round-cell tumor
Successful allogeneic bone marrow transplantation for chronic myelomonocytic leukemia complicated by refractory aortitis
Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation
Excessive toxicity of once daily i.v. BU, melphalan and thiotepa followed by auto SCT on patients with non-Hodgkin's lymphoma
Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin
Regionally limited or rare infections: prevention after hematopoietic cell transplantation